v3.25.1
Cover Page - shares
 3 Months Ended
Mar. 31, 2025
May 01, 2025
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Mar. 31, 2025  
Document Transition Report false  
Entity File Number 001-36483  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 47-1187261  
Entity Address, Address Line One 221 Crescent Street  
Entity Address, Address Line Two Suite 103A  
Entity Address, City or Town Waltham  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 02453  
City Area Code 617  
Local Phone Number 272-4600  
Title of 12(b) Security Common Stock, $0.01 par value per share  
Trading Symbol VRDN  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in share)   81,592,026
Entity Central Index Key 0001590750  
Amendment Flag false  
Document Fiscal Year Focus 2025  
Document Fiscal Period Focus Q1  
Current Fiscal Year End Date --12-31  
Entity Registrant Name Viridian Therapeutics, Inc./DE